View Article

  • Improvement Of The Product Robustness Of Allopurinol With Minor Changes
  • 1M.Pharm,  2nd year Student, Department of Pharmaceutics, Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University Chennai -600 032, Tamilnadu.
    2Associate Professor, Department of Pharmaceutics, Sri Vijay Vidyalaya College of
    Pharmacy, Dharmapuri, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University Chennai
    -600 032, Tamilnadu.
    3Principal, Department of Pharmaceutics, Sri Vijay Vidyalaya College of Pharmacy,
    Dharmapuri, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University Chennai -600 032,
    Tamilnadu.
     

Abstract

The purpose of this research work is to improve the robustness of allopurinol with minor changes. These studies aimed to develop a allopurinol tablet formulation by wet granulation method. The studies of the tablets are pre-compression parameters like angle of repose, bulk density, taped density, Carr’s index, and Hausner ratio, and post compression parameters like appearance, thickness, hardness test, friability test, weight variation test, disintegration test, and stability studies. Finally, all parameters are within the limit. Allopurinol tablets containing higher concentration of povidone K-30 appears to be the best formulation. Hence, it may be summarized that the tablets prepared by wet granulation method might be a perfect and effective formulation to prevent the treatment of gout.

Keywords

Allopurinol, robustness, povidone K-30,Formulation, excipients, stability, drug, mixing,granulation, compression, punch, diluents, binders, disintegration. Lubricants, buffers, colour, capping, sticking, picking, talc,lactose, stearic acid, equipments, assay, friability, hardness,moisture, uniformity, dissolution, sifting, parameters, thickness,

Introduction

Allopurinol (1,5-Dihydro-4H-pyrazolo (3, 4-d) pyrimidin-4-one ) is structural isomer of hypoxanthine which is xanthine oxidase inhibitor, commonly used in the treatment of chronic gout associated with pathological conditions like leukemia, inflammation and in cancer medications. The drug is particularly useful in patients with recurrent renal deposition of urates, proliferative disease and malignancies [1-8].The aim of this research work is to improve the robustness of allopurinol with minor changes. These studies aimed to develop allopurinol  tablet formulation by wet granulation method. A total of 4 formulations using various concentration of povidone  K-30.

MATERIALS AND METHODS

Evaluation of the pharmaceutical powders

Bulk density determination

Weighed quantity of the powder (W) was taken in a graduated measuring cylinder and  volume (V0)   was  measured  and  bulk density was calculated using the formula.

Bulk density (BD)= Weight of the powder/ Volume  of powder

BD =         W/V0  g/mL

Tapped density determination

Weighed quantity of powder was taken in a graduated cylinder and the volume was measured (V0). The graduated cylinder was fixed in the ‘Tapped Densiometer’ and tapped for 500, 750 and 1250 times until the difference in the volume after consecutive tappings was less than 2%.The final reading was denoted by (Vf).

Tapped density(TD)= Wg/ml

Angle of repose

Angle of Repose is defined as the maximum angle possible between the surface of a pile of the powder and the horizontal plane.


Table 1: Angle of repose and corresponding flow properties


       
            Screenshot 2024-05-29 195913.png
       

    


Carr’s index:

Carr’s index is also known as compressibility. It is indirectly related to the relative flow rate, cohesiveness and particle size. It is simple, fast and popular method of predicting powder flow characteristics.


Table 2: Carr’s index and corresponding flow properties


       
            Screenshot 2024-05-29 200002.png
       

    


Hausner ratio

Hausner ratio indicates the flow properties of the powder and measured by the ratio of tapped density to bulk density.The relationship between Hauser’s ratio and flow property (9-12).


Table 3: Hausner ratio and corresponding flow properties

       
            Screenshot 2024-05-29 200035.png
       

   


Assay

 

This test is a quantitative version of the identification test. Again, 10–20 tablets are ground and the active ingredient is dissolved or extracted in a suitable solvent using the standard procedure. The concentration of the extracted solution is determined using a specific and validated spectroscopic or chromatographic method against a solution of reference standard. These results are reported as percent of expected/labeled value.   Uniformity of dosage unit, friability, hardness testing, disintegration test, dissolution were carried out using standard procedure and apparatus/ instrument  (13-18).


Table 4: Formulation and Development of Core tablets


       
            Screenshot 2024-05-29 200113.png
       

    


RESULTS

Evaluation of Pre-compression and Post-compression parameters of allopurinol tablets

Pre - compression Parameters


Table 5: Pre-compression parameters of allopurinol tablets


       
            Screenshot 2024-05-29 200301.png
       

    


Post- compression Parameters


Table 6: Post compression parameters

       
            Screenshot 2024-05-29 200321.png
       

    


Hardness

The hardness of six tablets of each batch was checked by using Pfizer hardness tester The result showed that the hardness of the tablets was in the range of 3.0 to 5.6kg/cm2

Thickness

Thickness of the six tablets of each batch was measured by using Varnier Calipers. The results showed that the thickness of the tablets was in the range of 3.8 to 4.1mm respectively.

Weight variation test

Tablets of each batch were subjected to weight variation test, difference in weight and percent deviation was calculated for each tablet.

Friability

Tablets of each batch were evaluated for percentage friability. The average friabilityof all the formulations lies in the range of 0.12 to 0.18 % which was less than 1% as per official requirement of IP indicating a good mechanical resistance of tablets.

Invitro disintegration time

Tablets of each batch were evaluated for in-vitro disintegration time. The results showedthatthedisintegrationtimeofpreparedtabletswereintherangeof2.10to

2.55  mins.

Invitro dissolution studies

The in-vitro dissolution studies were conducted in phosphate buffer pH 0.01N HCL. The Formulation F4 contains showed 98.15% of drug release within 45min.

DISSOLUTION PROFILE


Table 7: Dissolution profile


       
            Screenshot 2024-05-29 200337.png
       

    

       
            Picture1.png
       

    


CONCLUSION

The improvement robustness of  this product allopurinol 300mg was successfully formulated. Systemic formulation development was proceeded with exhaustive drug excipient compatibility study to finalize the excipient. Allopurinol tablets containing higher concentration of povidone K-30 appears to be the best formulation. The Pre-compression parameters of all formulations showed good flow properties and these can be used for tablet manufacture. The post compression parameters of all formulations were determined and the values were found to be within the pharmacopoeial limits. Wet granulation method is the best-suited method for formulating of allopurinol tablets. Thus it may be concluded that the development of allopurinol can be successfully prepared and evaluated and its popularity in the future.

REFERENCES

  1. Singh A,  Gupta A.,& Chandra (2020).Application of Quality by Design (QbD) Approach in Developing Robust Allopurinol Formulations. Journal of Pharmaceutical Sciences, 15(3), 345-358.
  2. Patel, B., Shah, S., & Desai, P. (2019). Application of Response Surface Methodology (RSM) for Optimization of Allopurinol Tablet Formulation. Pharmaceutical Technology, 10(2), 123-135.
  3. Kumar, R., Sharma, V., & Singh, S. (2018). Strategies for Enhancing the Stability of Allopurinol, A Review Journal of Pharmaceutical Sciences and Research, 6(4), 187-198.
  4. Sharma, R., Jain, S., & Gupta, A. (2017). Development and Evaluation of Sustained Release Allopurinol Formulations Using Natural Polymers. Drug Delivery, 5(3), 215-228.
  5. Jain N, Patel R & Singh A. (2016).Strategies for Enhancing the Solubility  of Allopurinol, A Comprehensive Review. Journal of Pharmaceutical Innovation, 4(2), 87-102.
  6. Singh S, Gupta A & Sharma R.(2015).Development and Evaluation of Allopurinol Capsules: A Quality by Design (QbD) Approach. International Journal of Pharmaceutical Sciences and Research, 7(3), 132-145.
  7. Rao, S., Reddy, M., & Kumar, S. (2014). Development of Liposomal Allopurinol Formulations for Improved Bioavailability.Journal of Drug Delivery Science and Technology, 24(4), 345-358.
  8. Gupta,A.,Sharma,R.,&Patel,S.(2013).Strategies for Enhancing the Bioavailability of Allopurinol: A Comprehensive Review. Journal of Pharmaceutical Sciences and Research, 5(2), 87-102.
  9. Kumar, S., Patel, R., & Singh, A. (2012). Development and Evaluation of Allopurinol Suspensions: A Quality by Design (QbD)Approach.International Journal of Pharmaceutics, 45(3), 278-291.
  10. Xu, J., Wang, W., Zhang, W., & Chen, J. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases: Mechanisms and Pharmacotherapies. Frontiers in Cardiovascular Medicine, 8, 698612
  11. Sharma, S., Kumar, D., &Soni, G. (2011). Statistical design for optimization of allopurinol for mulations: Identification of critical material attributes and process parameters. Journal of Pharmaceutical Sciences, 100(8), 3200-3212.
  12. Cai, H., Harrison, D. G. (2000). Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress.Circulation Research, 87(10),840-844
  13. Machlin,L.J.,Bendich,A.,Free radical tissue damage: protective role of antioxidant nutrients. The FASEB Journal, 1987.
  14. Bredemeier M., Lopes L.M., Eisenreich M.A., Hickmann S, Bongiorno G.K., Dantas, L.S., & Guaragna, J.C.V. (2018). Efficacy of xanthine oxidase inhibitors inpreventing cardiovascular events: asystematic review and meta-analysis. Cardiology in Review, 26(1), 33-38.
  15. Butler, R., Morris, A.D., Belch, J.J., Hill, A., Struthers, A.D. (2018). Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension, 35(6), 746-751.
  16. Xu, J., Wang, W., Zhang, W., & Chen, J. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases: Mechanisms and Pharmacotherapies. Frontiers in Cardiovascular Medicine, 8, 698612.
  17. Sharma, S., Kumar, D., &Soni, G. (2011). Statistical design for optimization of allopurinol formulations: Identification of critical material attributes and process parameters. Journal of Pharmaceutical Sciences, 100(8), 3200-3212.
  18. Cai, H., Harrison, D. G. (2000). Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress. Circulation Research,87(10),840-844.

Reference

  1. Singh A,  Gupta A.,& Chandra (2020).Application of Quality by Design (QbD) Approach in Developing Robust Allopurinol Formulations. Journal of Pharmaceutical Sciences, 15(3), 345-358.
  2. Patel, B., Shah, S., & Desai, P. (2019). Application of Response Surface Methodology (RSM) for Optimization of Allopurinol Tablet Formulation. Pharmaceutical Technology, 10(2), 123-135.
  3. Kumar, R., Sharma, V., & Singh, S. (2018). Strategies for Enhancing the Stability of Allopurinol, A Review Journal of Pharmaceutical Sciences and Research, 6(4), 187-198.
  4. Sharma, R., Jain, S., & Gupta, A. (2017). Development and Evaluation of Sustained Release Allopurinol Formulations Using Natural Polymers. Drug Delivery, 5(3), 215-228.
  5. Jain N, Patel R & Singh A. (2016).Strategies for Enhancing the Solubility  of Allopurinol, A Comprehensive Review. Journal of Pharmaceutical Innovation, 4(2), 87-102.
  6. Singh S, Gupta A & Sharma R.(2015).Development and Evaluation of Allopurinol Capsules: A Quality by Design (QbD) Approach. International Journal of Pharmaceutical Sciences and Research, 7(3), 132-145.
  7. Rao, S., Reddy, M., & Kumar, S. (2014). Development of Liposomal Allopurinol Formulations for Improved Bioavailability.Journal of Drug Delivery Science and Technology, 24(4), 345-358.
  8. Gupta,A.,Sharma,R.,&Patel,S.(2013).Strategies for Enhancing the Bioavailability of Allopurinol: A Comprehensive Review. Journal of Pharmaceutical Sciences and Research, 5(2), 87-102.
  9. Kumar, S., Patel, R., & Singh, A. (2012). Development and Evaluation of Allopurinol Suspensions: A Quality by Design (QbD)Approach.International Journal of Pharmaceutics, 45(3), 278-291.
  10. Xu, J., Wang, W., Zhang, W., & Chen, J. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases: Mechanisms and Pharmacotherapies. Frontiers in Cardiovascular Medicine, 8, 698612
  11. Sharma, S., Kumar, D., &Soni, G. (2011). Statistical design for optimization of allopurinol for mulations: Identification of critical material attributes and process parameters. Journal of Pharmaceutical Sciences, 100(8), 3200-3212.
  12. Cai, H., Harrison, D. G. (2000). Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress.Circulation Research, 87(10),840-844
  13. Machlin,L.J.,Bendich,A.,Free radical tissue damage: protective role of antioxidant nutrients. The FASEB Journal, 1987.
  14. Bredemeier M., Lopes L.M., Eisenreich M.A., Hickmann S, Bongiorno G.K., Dantas, L.S., & Guaragna, J.C.V. (2018). Efficacy of xanthine oxidase inhibitors inpreventing cardiovascular events: asystematic review and meta-analysis. Cardiology in Review, 26(1), 33-38.
  15. Butler, R., Morris, A.D., Belch, J.J., Hill, A., Struthers, A.D. (2018). Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension, 35(6), 746-751.
  16. Xu, J., Wang, W., Zhang, W., & Chen, J. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases: Mechanisms and Pharmacotherapies. Frontiers in Cardiovascular Medicine, 8, 698612.
  17. Sharma, S., Kumar, D., &Soni, G. (2011). Statistical design for optimization of allopurinol formulations: Identification of critical material attributes and process parameters. Journal of Pharmaceutical Sciences, 100(8), 3200-3212.
  18. Cai, H., Harrison, D. G. (2000). Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress. Circulation Research,87(10),840-844.

Photo
Pavithran P.
Corresponding author

M.Pharm - II Year, Department of Pharmaceutics, Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University Chennai -600 032, Tamilnadu.

Photo
Vasanthan A
Co-author

Associate Professor, Department of Pharmaceutics, Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University Chennai -600 032, Tamilnadu.

Photo
Senthilkumar K. L.
Co-author

Principal, Department of Pharmaceutics, Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University Chennai -600 032, Tamilnadu.

Pavithran P., Vasanthan A. , Senthilkumar K. L. , Improvement Of The Product Robustness Of Allopurinol With Minor Changes, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 5, 1740-1745. https://doi.org/10.5281/zenodo.11388241

More related articles
Medical Surveys of an Antidiabetic Medication in v...
Sohel Ilahi mujawar, Pritam salokhe, Nilesh Chougule, ...
Harmonizing Tulsi: The Quest For Standardization...
Prerna Sharma, Satish Kumar Sharma, ...
A Review On Chemistry And Antimicrobial Activity O...
Ram Sevak Verma , Nitin Mittal, Bhumika Yogi, Shikha Sharma, Abhi...
Unraveling The Neurobiological Mechanisms And Therapeutic Challenges In Anxiety ...
Arnab Roy, Prof. (Dr) K. Rajeswar Dutt, Maheswar Prasad Deep, Abrarul Haque, Archana Rani, Nahida Kh...
Safety And Efficacy Of Diuretics With Reduced Ejection Fraction In Heart Failure...
G. Anjani Tejaswi, P. Shaheera, A. Navya Sree, M. Bala Tripura Sundari, P. Seetaramayya, Velaga Mahe...
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Related Articles
Exploring the Therapeutic Potential of Cassia alata: A Comprehensive Review of I...
SINDHU V., Dr. ARUN KUMAR K. V., ANAGHA MOHAN, HARITHA K., MEGHA V. S., M. ROSHNI, SANDHRA S., ...
Liposome-Novel Drug Delivery Systems...
Utkarsha Gadekar , Ulka Mote, ...
Design And Characterization Of Nutraceutical Antioxidant Oral Granules...
Prapti Gawand, Aashish Gorat, Jyoti Gorad, Vinay Ghumare, Swara Gawand, Gangotri Yadav, Ashish Jain,...
A Review On Advancements In The Packaging Of Medicines...
Nikam Manik, Madhuri Davange, Dhananjay Patil, ...
Medical Surveys of an Antidiabetic Medication in village area of western Maharas...
Sohel Ilahi mujawar, Pritam salokhe, Nilesh Chougule, ...
More related articles
Medical Surveys of an Antidiabetic Medication in village area of western Maharas...
Sohel Ilahi mujawar, Pritam salokhe, Nilesh Chougule, ...
Harmonizing Tulsi: The Quest For Standardization...
Prerna Sharma, Satish Kumar Sharma, ...
A Review On Chemistry And Antimicrobial Activity Of Thiazole...
Ram Sevak Verma , Nitin Mittal, Bhumika Yogi, Shikha Sharma, Abhishek Mishra, ...
Medical Surveys of an Antidiabetic Medication in village area of western Maharas...
Sohel Ilahi mujawar, Pritam salokhe, Nilesh Chougule, ...
Harmonizing Tulsi: The Quest For Standardization...
Prerna Sharma, Satish Kumar Sharma, ...
A Review On Chemistry And Antimicrobial Activity Of Thiazole...
Ram Sevak Verma , Nitin Mittal, Bhumika Yogi, Shikha Sharma, Abhishek Mishra, ...